Li Yaduo, Fan Ningning, He Xu, Zhu Jianjun, Zhang Jie, Lu Ligong
Medical Imaging Department, Zhuhai Clinical Medical College of Jinan University (Zhuhai People's Hospital), Zhuhai, People's Republic of China.
Department of Interventional Medicine, Guangzhou First People's Hospital, Guangzhou, People's Republic of China.
J Hepatocell Carcinoma. 2024 Jul 17;11:1429-1438. doi: 10.2147/JHC.S474922. eCollection 2024.
Hepatocellular Carcinoma (HCC) is a condition associated with significant morbidity and mortality. The presence of Portal Vein Tumour Thrombus (PVTT) typically signifies advanced disease stages and poor prognosis. Artificial intelligence (AI), particularly Machine Learning (ML) and Deep Learning (DL), has emerged as a promising tool for extracting quantitative data from medical images. AI is increasingly integrated into the imaging omics workflow and has become integral to various medical disciplines. This paper provides a comprehensive review of the mechanisms underlying the formation and progression of PVTT, as well as its impact on clinical management and prognosis. Additionally, it outlines the advancements in AI for predicting the diagnosis of HCC and the development of PVTT. The limitations of existing studies are critically evaluated, and potential future research directions in the realm of imaging for the diagnostic prediction of HCC and PVTT are discussed, with the ultimate goal of enhancing survival outcomes for PVTT patients.
肝细胞癌(HCC)是一种与高发病率和死亡率相关的疾病。门静脉肿瘤血栓(PVTT)的存在通常意味着疾病处于晚期且预后不良。人工智能(AI),特别是机器学习(ML)和深度学习(DL),已成为从医学图像中提取定量数据的一种有前途的工具。AI越来越多地融入成像组学工作流程,并已成为各个医学学科不可或缺的一部分。本文全面综述了PVTT形成和进展的潜在机制,以及其对临床管理和预后的影响。此外,还概述了AI在预测HCC诊断和PVTT发展方面的进展。对现有研究的局限性进行了批判性评估,并讨论了HCC和PVTT诊断预测成像领域未来潜在的研究方向,最终目标是提高PVTT患者的生存结果。